Eye mounted device for therapeutic agent release
US-12167978-B2 · Dec 17, 2024 · US
US9061069B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9061069-B2 |
| Application number | US-201013388114-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 2, 2010 |
| Priority date | Jul 31, 2009 |
| Publication date | Jun 23, 2015 |
| Grant date | Jun 23, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to the use of oligomers having constrained dipeptide or tripeptide motifs as agents for the vectorization of active ingredients.
Opening claim text (preview).
The invention claimed is: 1. An oligomer represented by the generic formula (I): R 6 —X 1 —(NR 1 —R-A-R′—CO) n —X 2 —R 7 (I) said oligomer contains R 6 or R 7 or both, in the case that R 6 or R 7 is present, at least one of R 6 or R 7 is an active ingredient (AI), optionally substituted active ingredient or a marker; in the case where R 6 is an active ingredient, which requires help through a cell membrane, or a marker, R 7 is selected from hydroxy, C 1 -C 6 alko…
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.